Skip to content
Indivior Pharmaceuticals, Inc.
 logo

Indivior Pharmaceuticals, Inc.

INDVNASDAQStock Fundamentals

Indivior Pharmaceuticals, Inc. is a drug manufacturers - specialty & generic company in the healthcare sector trading on NASDAQ, led by CEO Joseph J. Ciaffoni, with a market cap of $4.3B.

Market Cap$4.3B
Employees1.2K
CEOJoseph J. Ciaffoni
United States of America flag
CountryUnited States of America
Healthcare
Drug Manufacturers - Specialty & Generic
Most Recent EarningsApr 30, 2026 · 1 month 13 days agoQ1 2026
View report
Next EarningsJul 30, 2026 · in 2 monthsBefore Market Open · Q2 2026

Financials

Based on Q1 2026 filing

Indivior Pharmaceuticals, Inc.
 logo

Indivior Pharmaceuticals, Inc. FAQ

Common questions about Indivior Pharmaceuticals, Inc.

Indivior Pharmaceuticals, Inc. (INDV) has a market capitalization of $4.3B and trades on NASDAQ.

Indivior Pharmaceuticals, Inc. has approximately 1,164 employees.